{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:13:23Z","timestamp":1792872803382,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019175","name":"Scleroderma Society of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.berh.2026.102156","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:50:06Z","timestamp":1779709806000},"page":"102156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-7049","authenticated-orcid":false,"given":"Carlos Enrique","family":"Toro-Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Quintana-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2026.102156_bib1","series-title":"Rheumatology","first-page":"3121","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","author":"Bairkdar","year":"2021"},{"key":"10.1016\/j.berh.2026.102156_bib2","series-title":"Current opinion in rheumatology","first-page":"122","article-title":"Scleroderma epidemiology update","author":"Calderon","year":"2021"},{"issue":"1","key":"10.1016\/j.berh.2026.102156_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2479238","article-title":"Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis","volume":"57","author":"Mahakkanukrauh","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.berh.2026.102156_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11926-003-0045-1","article-title":"Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations","volume":"5","author":"Reveille","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10.1016\/j.berh.2026.102156_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.berh.2026.102156_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2026.102156_bib7","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2026.102156_bib8","unstructured":"CHECKLIST FOR SYSTEMATIC REVIEWS AND RESEARCH SYNTHESES. Critical Appraisal tools for use in JBI Systematic Reviews. p. 1\u20137."},{"key":"10.1016\/j.berh.2026.102156_bib9","series-title":"The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis","author":"Wells","year":"2000"},{"key":"10.1016\/j.berh.2026.102156_bib10","series-title":"International journal of rheumatic diseases","first-page":"2096","article-title":"Prevalence and incidence of systemic sclerosis: a systematic review and meta-analysis","author":"Zhong","year":"2019"},{"key":"10.1016\/j.berh.2026.102156_bib11","series-title":"Current opinion in rheumatology","first-page":"103","article-title":"A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024","author":"Good","year":"2025"},{"issue":"4","key":"10.1016\/j.berh.2026.102156_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2026.102156_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.reuma.2014.01.011","article-title":"Scleroderma in the Caribbean: characteristics in a Dominican case series","volume":"10","author":"Gottschalk","year":"2014","journal-title":"Reumatol Cl\u00ednica"},{"key":"10.1016\/j.berh.2026.102156_bib14","article-title":"Long-term epidemiology of systemic Sclerosis in Western Australia: a population-level linked data study","author":"Host","year":"2025","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2026.102156_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152594","article-title":"High prevalence and incidence of systemic sclerosis in Reunion Island, a French multi-ethnical and tropical territory","volume":"70","author":"Dubernet","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2026.102156_bib16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","article-title":"The incidence, prevalence, and survival of systemic sclerosis in the UK clinical Practice Research Datalink","volume":"37","author":"Royle","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/RHU.0b013e31820e7e8d","article-title":"Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires","volume":"17","author":"Rosa","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.berh.2026.102156_bib18","article-title":"Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study","volume":"35","author":"Muntyanu","year":"2024","journal-title":"Lancet Reg Health, Am"},{"issue":"5","key":"10.1016\/j.berh.2026.102156_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MD.0b013e318189372f","article-title":"Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study","volume":"87","author":"Arias-Nu\u00f1ez","year":"2008","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.berh.2026.102156_bib20","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102156_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semarthrit.2018.11.002","article-title":"Contemporary epidemiology of systemic sclerosis: a population-based cohort study in the United Kingdom","volume":"49","author":"Garc\u00eda Rodr\u00edguez","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2397198319873526","article-title":"Prevalence of systemic sclerosis in Colombia: data from the national Health Registry 2012\u20132016","volume":"5","author":"Fern\u00e1ndez-\u00c1vila","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.berh.2026.102156_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151978","article-title":"Incidence and prevalence of systemic sclerosis in Sweden, 2004\u20132015, a register-based study","volume":"53","author":"Westerlind","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2026.102156_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/14799731221125559","article-title":"Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: a nationwide retrospective cohort study","volume":"19","author":"Knarborg","year":"2022","journal-title":"Chron Respir Dis"},{"issue":"9","key":"10.1016\/j.berh.2026.102156_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/rheumatology\/kes076","article-title":"Prevalence of systemic sclerosis in south-east Norway","volume":"51","author":"Hoffmann-Vold","year":"2012","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.rbr.2016.05.008","article-title":"Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil","volume":"57","author":"Horimoto","year":"2017","journal-title":"Rev Bras Reumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/23971983221145788","article-title":"Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates systemic sclerosis Registry","volume":"8","author":"Namas","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.berh.2026.102156_bib28","series-title":"Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States. JMCP.org","author":"Fan","year":"2020"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2397198318763701","article-title":"Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States","volume":"3","author":"Beukelman","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"10.1016\/j.berh.2026.102156_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102156_bib32","series-title":"Pan African Medical journal","first-page":"1","article-title":"Systemic sclerosis in Sub-Saharan Africa: a systematic review","author":"Erzer","year":"2020"},{"issue":"6","key":"10.1016\/j.berh.2026.102156_bib33","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/rheumatology\/keac576","article-title":"Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region","volume":"62","author":"Lescoat","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102156_bib34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3899\/jrheum.121380","article-title":"The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review","author":"Muangchan","year":"2013","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1378\/chest.12-2768","article-title":"Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study","volume":"144","author":"Bauer","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.berh.2026.102156_bib36","first-page":"20","article-title":"Comorbidity and mortality in systemic sclerosis and matched controls: impact of interstitial lung disease. A population based cohort study based on health registry data","author":"Knarborg","year":"2023","journal-title":"Chron Respir Dis"},{"issue":"12","key":"10.1016\/j.berh.2026.102156_bib37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/1756-185X.14206","article-title":"Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: a systematic review and meta-analysis","volume":"24","author":"Qiu","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2026.102156_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.berh.2026.102156_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.berh.2026.102156_bib40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamadermatol.2023.1729","article-title":"Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma: data from the international EUSTAR database","volume":"159","author":"Lescoat","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102156_bib41","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2026.102156_bib42","series-title":"Autoimmunity reviews","article-title":"The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: systematic review and meta-analysis","author":"Rubio-Rivas","year":"2021"},{"issue":"4","key":"10.1016\/j.berh.2026.102156_bib43","first-page":"375","article-title":"Pulmonary arterial hypertension incidence in patients with systemic sclerosis treated with Bosentan for digital ulcers: evidence from the SPRING-SIR registry","volume":"52","author":"Cacciapaglia","year":"2025","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102156_bib44","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2026.102156_bib45","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.mayocp.2019.12.015","article-title":"Cardiovascular risk factors and atherosclerotic cardiovascular events among incident cases of systemic sclerosis: results from a population-based cohort (1980-2016)","volume":"95","author":"Kurmann","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.berh.2026.102156_bib46","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/rheumatology\/kead464","article-title":"The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study","volume":"63","author":"Yen","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102156_bib47","series-title":"Molliere et al. Clinical and Experimental Rheumatology","article-title":"Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort gastrointestinal disorders in SSc\/C","author":"Molli\u00e8re","year":"2022"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5603\/PJNNS.a2023.0018","article-title":"Prevalence of polyneuropathies among systemic sclerosis patients and impact on health-related quality of life","volume":"57","author":"Ivanova","year":"2023","journal-title":"Neurol Neurochir Pol"},{"issue":"7","key":"10.1016\/j.berh.2026.102156_bib49","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s10067-025-07449-1","article-title":"Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology","volume":"44","author":"Orlandi","year":"2025","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102156_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102156_bib51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2026.102156_bib52","article-title":"Revolutionizing clinical trials in systemic sclerosis","volume":"11","author":"Nuaaman","year":"2025","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102156_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-2080-y","article-title":"Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden","volume":"21","author":"Morrisroe","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.berh.2026.102156_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/resp.14234","article-title":"Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: a nationwide population-based cohort study","volume":"27","author":"Knarborg","year":"2022","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.berh.2026.102156_bib55","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.140006","article-title":"The effect of male sex on survival in systemic sclerosis","volume":"41","author":"Hussein","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102156_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-0933-1","article-title":"Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study","volume":"18","author":"Pasarikovski","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.berh.2026.102156_bib57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3899\/jrheum.180042","article-title":"Ethnic variations in systemic sclerosis disease manifestations, internal organ involvement, and mortality","volume":"46","author":"Al-Sheikh","year":"2019","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102156_bib58","first-page":"1123","article-title":"Scleroderma: Health Services utilization from patients\u2019 perspective","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2026.102156_bib59","series-title":"Rheumatology","first-page":"3123","article-title":"Healthcare utilization and economic burden in systemic sclerosis: a systematic review","author":"Martin Calderon","year":"2022"},{"issue":"9","key":"10.1016\/j.berh.2026.102156_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102602","article-title":"Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)","volume":"19","author":"Jiang","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:45:57Z","timestamp":1781509557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1521694226000410"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102156","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102156"}}